Article

Campaign against squinting

Transitions Optical Inc. has a new campaign and contest, ?Life Less Squinty,? designed to promote the benefits of its lenses for glare and ultraviolet light protection.

Pinellas Park, FL-Transitions Optical Inc. has a new campaign and contest, “Life Less Squinty,” designed to promote the benefits of its lenses for glare and ultraviolet light protection.

Through June 30, patients can participate in a “15 Minutes of Fame” contest by visiting www.LifeLessSquinty.com to upload a photo that demonstrates their best “squinty” face. Photos will be posted to the site’s “Squinty Billboard,” and up to 60 winners will be selected to have their photos featured on real billboards in New York/New Jersey, Chicago, Philadelphia, Dallas, or Atlanta. Participants also will have the chance to share their photos via Facebook and Twitter.

The Life Less Squinty Web site features a series of interactive banners designed to reinforce the potential consequences of squinting-such as premature aging and diminished sex appeal-and show how the company’s lenses are designed to adapt automatically to provide vision in changing outdoor lighting conditions and reduce squinting. The site offers a side-by-side comparison of the company’s family of products and encourages patients to visit their eye-care professionals to learn more.

Eye-care professionals can align their local marketing efforts with the campaign by sharing the www.LifeLessSquinty.com link on their practice Web sites and Facebook pages. Customizable counter cards and postcards are available through the Transitions Online Marketing tool at www.TransitionsTOM.com.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.